VistaGen Therapeutics CEO and Key Executive Team

• Shawn K. Singh

  Chief Executive Officer and Director
• Jon S. Saxe

  Chairman of the Board
• Jerry Gin

  Director
• Ann Cunningham

  Chief Commercial Officer and Director
• Joanne Curley

  Director
• H. Ralph Snodgrass

  President and Chief Scientific Officer
• Mark A. Smith

  Chief Medical Officer
• Mark A. McPartland

  Vice President of Corporate Development
• Jerrold D. Dotson

  Vice President, Chief Financial Officer and Secretary
• Mark J. Ginski

  Senior Vice President, Head of CMC
• Mary L. Rotunno

  Director
• Maggie Fitzpatrick

  Director
• Louis Monti

  Vice President, Translational Medicine
• Jaakko Lappalainen

  Senior Vice President, Global Clinical Development and Pharmacovigilance
• Erik Berglund

  Vice President, Global Regulatory Affairs
• Ross A. Baker

  Vice President, Global Medical Affairs
• Mark Flather

  Vice President, Investor Relations
• Rita E. Hanover

  Vice President, Biostatistics and Clinical Analytics
• Ellis Wilson

  Vice President, Global Clinical Operations
• Allen Cato

  Senior Vice President, Development Operations

Source: vistagen.com, vistagen.com, ir.vistagen.com, vistagen.com, vistagen.com, vistagen.com, ir.vistagen.com, ir.vistagen.com